Cargando…

New Injection Points of Onabotulinum Toxin A for Spastic Paralysis of the Fingers: Eight Cases of Report

OBJECTIVE: Onabotulinum toxin A (botulinum A toxin) is utilized to extend flexed extremities in spastic hemiparesis. Injection points are important to obtain a better effect. Injecting botulinum A toxin into the forearm muscles is a standard method for flexed wrist and fingers; however, we developed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamada, Shoko Merrit, Takashima, Shinnosuke, Takaoka, Yoshiro, Matsuura, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313568/ https://www.ncbi.nlm.nih.gov/pubmed/32606524 http://dx.doi.org/10.4103/aian.AIAN_360_18

Ejemplares similares

Onabotulinum toxin-A (Botox) for spastic equinus in cerebral palsy: a prospective kinematic study
por: Hastings-Ison, T., et al.
Publicado: (2018)

Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity
por: Rohrsted, Malene, et al.
Publicado: (2012)

Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study
por: García-Azorín, David, et al.
Publicado: (2022)

Pelvic-Spinal Analysis and the Impact of Onabotulinum toxin A Injections on Spinal Balance in one Child With Cerebral Palsy
por: Chaléat-Valayer, Emmanuelle, et al.
Publicado: (2016)

Repeated onabotulinum neurotoxin A injections for drooling in children with neurodisability
por: Bekkers, Stijn, et al.
Publicado: (2021)

Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations
por: Barbanti, Piero, et al.
Publicado: (2017)

The Role of Onabotulinum Toxin Type A in the Management of Chronic Non-migraine Headaches
por: Jia, Cassie, et al.
Publicado: (2019)

Intradetrusor Injections of Onabotulinum Toxin-A in Children With Urinary Incontinence due to Neurogenic Detrusor Overactivity Refractory to Antimuscarinic Treatment
por: Tarcan, Tufan, et al.
Publicado: (2014)

Onabotulinum toxin A vs. incobotulinum toxin A for the treatment of chronic migraine: a retrospective review
por: Lucchese, Scott, et al.
Publicado: (2023)

Bladder diverticuli following injection of onabotulinum toxin A in a patient with multiple sclerosis and autosomal dominant polycystic kidney disease
por: Raza, Syed Imran, et al.
Publicado: (2018)

Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation
por: Trinh, Hamilton, et al.
Publicado: (2019)

Injection of Onabotulinum Toxin A into the Bilateral External Oblique Muscle Attenuated Camptocormia: A Prospective Open-Label Study in Six Patients with Parkinson’s Disease
por: Todo, Hiroyuki, et al.
Publicado: (2018)

Onabotulinum Toxin A Intradetrusor Injections in Children with Neurogenic Lower Urinary Tract Dysfunction: Long-Term Histological Effects on the Bladder Wall
por: Pellegrino, Chiara, et al.
Publicado: (2023)

EHMTI-0278. Onabotulinum toxin a for hemicrania continua: a case series of 8 patients
por: Miller, S, et al.
Publicado: (2014)

Further Evidence that Onabotulinum Toxin is a Viable Treatment Option for Pediatric Chronic Migraine Patients
por: Ali, Sameer S, et al.
Publicado: (2019)

Efficacy of Onabotulinum Toxin A on Obsessive–Compulsive Traits in a Population of Chronic Migraine Patients
por: Viticchi, Giovanna, et al.
Publicado: (2022)

Long‐Term Outcome of Patients With Intractable Chronic Cluster Headache Treated With Injection of Onabotulinum Toxin A Toward the Sphenopalatine Ganglion – An Observational Study
por: Aschehoug, Irina, et al.
Publicado: (2018)

Spastic and Syphilitic Spinal Paralysis
Publicado: (1902)

Onabotulinum toxin type A injection into the triceps unmasks elbow flexion in infant brachial plexus birth palsy: A retrospective observational cohort study
por: Morscher, Melanie A., et al.
Publicado: (2020)

The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia
por: Chen, Yen-Ting, et al.
Publicado: (2020)

The Surgical Treatment of Spastic Infantile Paralysis
Publicado: (1902)

The Treatment of Spastic Paralysis by Sympathetic Ramisection
Publicado: (1925)

Spastic Paralysis; Talipes Equino-Varus
por: Owen, Edmon
Publicado: (1895)

Are There Trigger Points in the Spastic Muscles? Electromyographical Evidence of Dry Needling Effects on Spastic Finger Flexors in Chronic Stroke
por: Lu, Zhiyuan, et al.
Publicado: (2020)

Evaluation of the effect of 100U of Onabotulinum toxin A on detrusor contractility in women with idiopathic OAB: A multicentre prospective study
por: De Rienzo, Gaetano, et al.
Publicado: (2021)

Non-surgical Brachioplexy Using Polydioxanone Threads and Onabotulinum Toxin Type A in an Indian Female Patient: A Case Report
por: Arora, Reema Tebak, et al.
Publicado: (2022)

Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker
por: Bumb, Anja, et al.
Publicado: (2013)

Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis
por: El Kahky, Hanan Mohamed, et al.
Publicado: (2013)

Botulinum Toxin Injection for Spastic Scapular Dyskinesia After Stroke: Case Series
por: Hou, Saiyun, et al.
Publicado: (2015)

A Case of Trigger-Point Injection-Induced Hypokalemic Paralysis
por: Soriano, Paolo K., et al.
Publicado: (2017)

Changes in bone mineral density in unconscious immobile stroke patients from the acute to chronic phases of brain diseases
por: Yamada, Shoko Merrit
Publicado: (2022)

Treatment of lateral canthal rhytides with a medium depth chemical peel with or without pretreatment with onabotulinum toxin type A: a randomized control trial
por: Tung, Rebecca, et al.
Publicado: (2016)

Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study
por: Corbelli, Ilenia, et al.
Publicado: (2022)

A Literature Review on the Efficacy and Safety of Botulinum Toxin: An Injection in Post-Stroke Spasticity
por: Ghasemi, Majid, et al.
Publicado: (2013)

Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution
por: Choi, Ja Young, et al.
Publicado: (2016)

Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2014)

Botulinum toxin treatment of spasticity targeted to muscle endplates: an international, randomised, evaluator-blinded study comparing two different botulinum toxin injection strategies for the treatment of upper limb spasticity
por: Rekand, Tiina, et al.
Publicado: (2019)

Botulinum toxin injection improved voluntary motor control in selected patients with post-stroke spasticity☆
por: Chang, Shuo-Hsiu, et al.
Publicado: (2012)

Evaluation of the Spasticity after Botulinum Toxin Injection Using Paired-Pulse Transcranial Magnetic Stimulation
por: Chia, Chin-Hsuan, et al.
Publicado: (2018)

Synergic use of botulinum toxin injection and radial extracorporeal shockwave therapy in Multiple Sclerosis spasticity
por: Marinaro, Cinzia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1o1er5shnbga4em9nlbbrjf3j1